Intrathecal CRISPR-Edited Allogeneic IL-13Rα2 CAR T Cells for Recurrent High-Grade Glioma: Preclinical Characterization and Phase I Trial

By
Emily Salmini
-
0
101
Scientists generated off-the-shelf CRISPR-Cas9–edited IL-13Rα2-specific allogeneic universal CAR-T cells
[Nature Communications]
Abstract